Come up with a name for your new list and we'll add to it:
SHEPHERD Therapeutics raised a round of funding on July 12, 2017. Investors include
Harvard Venture Incubation Program.
SHEPHERD Therapeutics is a biotechnology company that seeks to develop therapies for rare cancers in a faster and more cost-efficient way than what is available elsewhere on the market.…